The STELLAR trial is intended for patients who have recently been diagnosed with malignant pleural mesothelioma. This clinical trial is the first one evaluating the safety and efficacy of the NovoTTF-100L System for this indication, when combined with the standard chemotherapy normally given to patients in this condition. This System delivers Tumor Treating Fields (TTFields) to the cancer in the lungs region. Novocure Ltd., the trial sponsor, maintains this website to help patients get basic information about the clinical trial and facilitate their accessibility to medical centers that offer participation in the trial. If you would like to take part in the STELLAR trial, please contact one of the participating centers as soon as possible. If you have questions concerning your medical condition and recommended treatment, please consult with your treating doctor.